The biopharmaceutical company Ability Pharmaceuticals SL announced today that the full description of the mechanism of action of ABTL0812 has been published in the prestigious Autophagy journal (impac...
Read moreA study led by researchers from the Institut de Neurociències (INc-UAB), in collaboration with the Institute for Advanced Chemistry of Catalonia (IQAC-CSIC), describes a new mechanism by which the an...
Read moreAgnès Arbat and Ignasi Canals lead Oxolife, a startup that is developing OXO-001, a drug with the potential to treat female infertility as it increases the chances of embryo implantation a 65%. Arba...
Read moreThe biotech company Oxolife, created to develop a new treatment to improve the female fertility rate, completed its first funding round by raising 5,000,000 euros in an investment led by Inveready Ass...
Read moreInvestigadores del Instituto Broad de la Universidad de Harvard y el Instituto de Tecnología de Massachusetts han encontrado que la proteína Cas9 del sistema CRISPR de edición genómica puede tener...
Read moreLa pasada semana se constituyó como empresa Libera Bio, una spin-off de la Universidade de Santiago de Compostela dedicada al desarrollo de nuevos medicamentos biológicos anticancerígenos basados e...
Read moreOryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with strong unmet medical need, announced today...
Read moreInvestigadores del Cima Universidad de Navarra identifican los mecanismos que bloquean las etapas previas del cáncer de hígado
Read moreIn this review, the authors extensively collect the established knowledge on germination control from a genetic and molecular perspective, incorporating the latest advances in the field
Read moreTras validar la bioactividad de dos fármacos antiinflamatorios para impedir la replicación del virus del SARS-CoV-2 y fruto del mismo estudio, la iniciativa Covid Moonshot, confirmó que un tercer f...
Read moreResearchers from the Research Group on Lipids and Cardiovascular Pathology at IR Sant Pau and IIBB-CSIC, led by Dr. Vicenta Llorente, have published an article in Theranosthics.
Read more